Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Drug Resistance

  Free Subscription

Articles published in AIDS

Retrieve available abstracts of 22 articles:
HTML format
Text format

Single Articles

    January 2016
  1. CASADELLA M, Noguera-Julian M, Sunpath H, Gordon M, et al
    Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing.
    AIDS. 2016.
    PubMed     Text format     Abstract available

  2. WEIS JF, Baeten JM, McCoy CO, Warth C, et al
    Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation.
    AIDS. 2016;30:31-5.
    PubMed     Text format     Abstract available

  3. VAN LUNZEN J, Antinori A, Cohen CJ, Arribas JR, et al
    Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study.
    AIDS. 2016;30:251-9.
    PubMed     Text format     Abstract available

    November 2015
  4. KONOU AA, Dagnra AY, Vidal N, Salou M, et al
    Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo.
    AIDS. 2015;29:2527-30.
    PubMed     Text format     Abstract available

    September 2015
  5. WINAND R, Theys K, Eusebio M, Aerts J, et al
    Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals.
    AIDS. 2015;29:2045-52.
    PubMed     Text format     Abstract available

  6. MOURAD R, Chevennet F, Dunn DT, Fearnhill E, et al
    A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UK.
    AIDS. 2015;29:1917-25.
    PubMed     Text format     Abstract available

  7. OLIVEIRA M, Mesplede T, Moisi D, Ibanescu RI, et al
    The dolutegravir R263K resistance mutation in HIV-1 integrase is incompatible with the emergence of resistance against raltegravir.
    AIDS. 2015.
    PubMed     Text format     Abstract available

    August 2015
  8. PETERSON CW, Haworth KG, Polacino P, Huang ML, et al
    Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation.
    AIDS. 2015;29:1597-606.
    PubMed     Text format     Abstract available

    July 2015
  9. LOPES GI, Coelho LP, Hornke L, Volpato AP, et al
    Transmission of a multidrug-resistant HIV-1 from an occupational exposure, in Sao Paulo, Brazil.
    AIDS. 2015;29:1580-3.
    PubMed     Text format    

  10. CASADELLA M, Manzardo C, Noguera-Julian M, Ferrer E, et al
    Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced disease.
    AIDS. 2015;29:1493-504.
    PubMed     Text format     Abstract available

  11. OLSON SC, Ngo-Giang-Huong N, Beck I, Deng W, et al
    Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission.
    AIDS. 2015;29:1467-71.
    PubMed     Text format     Abstract available

  12. MESPLEDE T, Quashie PK, Hassounah S, Osman N, et al
    The R263K substitution in HIV-1 subtype C is more deleterious for integrase enzymatic function and viral replication than in subtype B.
    AIDS. 2015;29:1459-66.
    PubMed     Text format     Abstract available

    New study suggests resistance testing may not be best use of resources for HIV treatment programmes in low-income settings.
    AIDS. 2015;29:N7.
    PubMed     Text format    

  14. NELSON JA, Fokar A, Hudgens MG, Compliment KJ, et al
    Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis: results of the Breastfeeding, Antiretrovirals and Nutrition study.
    AIDS. 2015.
    PubMed     Text format     Abstract available

  15. LIMA VD, Reuter A, Harrigan PR, Lourenco L, et al
    Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes.
    AIDS. 2015.
    PubMed     Text format     Abstract available

    June 2015
  16. ALESSANDRI-GRADT E, Morgand M, Delaugerre C, Peytavin G, et al
    HIV-1 group O resistance pathway with raltegravir is similar to HIV-1 group M.
    AIDS. 2015;29:1271-3.
    PubMed     Text format    

  17. BONADIES G, Maraolo AE, Tambaro O, Palmiero G, et al
    Dolutegravir: successful experience in a challenging patient.
    AIDS. 2015;29:1269-71.
    PubMed     Text format    

  18. PERE H, Roques P, Talla F, Meillo H, et al
    Sustained virological failure in Cameroonese patient infected by HIV-1 group N evidenced by sequence-based genotyping assay.
    AIDS. 2015;29:1267-9.
    PubMed     Text format    

  19. THIO CL, Smeaton L, Hollabaugh K, Saulynas M, et al
    Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks.
    AIDS. 2015;29:1173-82.
    PubMed     Text format     Abstract available

  20. SCHULTZE A, Phillips AN, Paredes R, Battegay M, et al
    HIV resistance testing and detected drug resistance in Europe.
    AIDS. 2015.
    PubMed     Text format     Abstract available

    May 2015
  21. ABECASIS AB, van Laethem K, Theys K
    Lack of evidence for the selection of E138 mutations by first-generation non-nucleoside reverse transcriptase inhibitors in patients infected with HIV-1 non-B subtypes.
    AIDS. 2015;29:987-8.
    PubMed     Text format    

    April 2015
  22. LI JZ, Smith DM, Mellors JW
    The critical roles of treatment interruption studies and biomarker identification in the search for an HIV cure.
    AIDS. 2015.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.